DE GIOVANNI, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 651
EU - Europa 229
AS - Asia 33
AF - Africa 16
SA - Sud America 8
Totale 937
Nazione #
US - Stati Uniti d'America 644
IT - Italia 69
FR - Francia 35
DE - Germania 34
IE - Irlanda 31
VN - Vietnam 12
BG - Bulgaria 11
EG - Egitto 10
GB - Regno Unito 10
NL - Olanda 8
SE - Svezia 8
CA - Canada 7
AE - Emirati Arabi Uniti 6
CN - Cina 6
FI - Finlandia 6
ZA - Sudafrica 6
CL - Cile 5
UA - Ucraina 4
BR - Brasile 3
CZ - Repubblica Ceca 3
BE - Belgio 2
GR - Grecia 2
IR - Iran 2
JP - Giappone 2
RU - Federazione Russa 2
SI - Slovenia 2
CH - Svizzera 1
HK - Hong Kong 1
IN - India 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
TW - Taiwan 1
Totale 937
Città #
Fairfield 71
Ashburn 69
Santa Cruz 52
Houston 42
Seattle 38
Woodbridge 34
Buffalo 31
Dublin 31
Wilmington 24
Bremen 15
Cambridge 12
Bologna 11
Columbus 11
Rome 11
Sofia 11
Ann Arbor 10
Ravenna 10
Chicago 9
Boardman 8
Milan 8
Southend 7
Stockholm 7
Cairo 6
Helsinki 6
Los Angeles 6
Ottawa 6
Council Bluffs 5
Las Vegas 5
Milpitas 5
Muizenberg 5
New York 5
Phoenix 5
Brescia 4
Clearwater 4
Dallas 4
Dong Ket 4
San Diego 4
Torino 4
Henderson 3
Lake Forest 3
Munich 3
Padova 3
Paris 3
Riva 3
University Park 3
Berlin 2
Cedar Knolls 2
Fleming Island 2
Freiburg 2
Provo 2
Ruckersville 2
Saint-Quentin-Fallavier 2
San Francisco 2
Turin 2
Vicenza 2
Yellow Springs 2
Amsterdam 1
Ancona 1
Andover 1
Auburn 1
Bellevue 1
Brookline 1
Brussels 1
Bucharest 1
Büdelsdorf 1
Central 1
Centro 1
Chandler 1
Changsha 1
Crugers 1
Denver 1
Dietikon 1
Edison 1
Gif-sur-Yvette 1
Gunzenhausen 1
Hazerswoude-Dorp 1
Indiana 1
Islington 1
Jaboatao dos Guararapes 1
Kolomyya 1
Leesburg 1
Lincoln 1
Marseille 1
Miami 1
Nagareyama 1
Naples 1
New Orleans 1
Pasadena 1
Portici 1
Portland 1
Providence 1
Recife 1
Redmond 1
Reston 1
Saint Petersburg 1
San Antonio 1
San Giorgio di Piano 1
San Mateo 1
Scottsdale 1
Scranton 1
Totale 687
Nome #
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus., file e1dcb32c-2949-7715-e053-1705fe0a6cc9 118
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis, file e1dcb332-6324-7715-e053-1705fe0a6cc9 96
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor, file e1dcb32c-28ee-7715-e053-1705fe0a6cc9 95
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model, file e1dcb333-923c-7715-e053-1705fe0a6cc9 95
Preclinical HER-2 Vaccines: From Rodent to Human HER-2, file e1dcb331-a140-7715-e053-1705fe0a6cc9 83
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft, file e1dcb337-0581-7715-e053-1705fe0a6cc9 77
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R, file e1dcb332-d495-7715-e053-1705fe0a6cc9 72
Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells, file e1dcb335-6de6-7715-e053-1705fe0a6cc9 71
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis, file e1dcb32c-9005-7715-e053-1705fe0a6cc9 67
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2., file e1dcb330-306b-7715-e053-1705fe0a6cc9 64
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy, file e1dcb337-f0cb-7715-e053-1705fe0a6cc9 51
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R, file e1dcb335-33b1-7715-e053-1705fe0a6cc9 20
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression, file e1dcb338-7909-7715-e053-1705fe0a6cc9 17
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis, file e1dcb331-3775-7715-e053-1705fe0a6cc9 11
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression, file cc726988-ca04-4893-af11-685d3898467b 8
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice., file e1dcb32c-2ea4-7715-e053-1705fe0a6cc9 6
Herpesviruses as oncolytic agents, file e1dcb32c-0cb6-7715-e053-1705fe0a6cc9 5
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model, file e1dcb335-1a08-7715-e053-1705fe0a6cc9 5
Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells, file e1dcb335-6a6a-7715-e053-1705fe0a6cc9 4
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas, file e1dcb32c-c4c6-7715-e053-1705fe0a6cc9 3
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response, file e1dcb330-0111-7715-e053-1705fe0a6cc9 3
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis, file e1dcb335-54e2-7715-e053-1705fe0a6cc9 3
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice., file e1dcb330-8a9d-7715-e053-1705fe0a6cc9 2
Totale 976
Categoria #
all - tutte 2.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020154 0 3 0 5 17 16 19 20 24 20 14 16
2020/2021194 15 21 14 10 5 16 20 19 19 15 23 17
2021/2022219 10 9 17 11 24 6 12 14 11 7 71 27
2022/2023255 8 10 61 50 12 9 8 16 35 8 32 6
2023/2024149 8 5 13 11 21 29 6 12 18 12 14 0
Totale 976